Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho-Cheol Hong

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Maturitas|January 30, 2015
Waist-to-hip ratio is better at predicting subclinical atherosclerosis than body mass index and waist circumference in postmenopausal womenHyun Jung Lee, Soon Young Hwang, Ho Cheol Hong, et al.
Metabolism: Clinical and Experimental|May 7, 2013
Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination SurveyHo Cheol Hong, Ji-Sung Lee, Hae Yoon Choi, et al.
Biochemical Pharmacology|August 23, 2015
A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expressionHwan-Jin Hwang, Tae Woo Jung, Baek-Hui Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2012
Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trialKyung Mook Choi, Kyung Ah Han, Hee Jung Ahn, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2014
Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humansHae Yoon Choi, Sungeun Kim, Ji Woo Park, et al.
Plos One|December 18, 2014
Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic Obesity Study (KSOS)Tae Nyun Kim, Man Sik Park, Ja Young Ryu, et al.
Diabetes & Metabolism Journal|February 27, 2013
Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver diseaseHae Yoon Choi, Soon Young Hwang, Chang Hee Lee, et al.
Molecular and Cellular Endocrinology|May 13, 2014
Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytesHwan-Jin Hwang, Tae Woo Jung, Ja Young Ryu, et al.
Molecular and Cellular Endocrinology|February 10, 2015
The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanismsHwan-Jin Hwang, Hye Soo Chung, Tae Woo Jung, et al.
Endocrine|March 28, 2013
Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitusHye Jin Yoo, Soon Young Hwang, Ho Cheol Hong, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Maturitas|January 30, 2015
Waist-to-hip ratio is better at predicting subclinical atherosclerosis than body mass index and waist circumference in postmenopausal womenHyun Jung Lee, Soon Young Hwang, Ho Cheol Hong, et al.
Metabolism: Clinical and Experimental|May 7, 2013
Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination SurveyHo Cheol Hong, Ji-Sung Lee, Hae Yoon Choi, et al.
Biochemical Pharmacology|August 23, 2015
A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expressionHwan-Jin Hwang, Tae Woo Jung, Baek-Hui Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2012
Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trialKyung Mook Choi, Kyung Ah Han, Hee Jung Ahn, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2014
Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humansHae Yoon Choi, Sungeun Kim, Ji Woo Park, et al.
Plos One|December 18, 2014
Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic Obesity Study (KSOS)Tae Nyun Kim, Man Sik Park, Ja Young Ryu, et al.
Diabetes & Metabolism Journal|February 27, 2013
Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver diseaseHae Yoon Choi, Soon Young Hwang, Chang Hee Lee, et al.
Molecular and Cellular Endocrinology|May 13, 2014
Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytesHwan-Jin Hwang, Tae Woo Jung, Ja Young Ryu, et al.
Molecular and Cellular Endocrinology|February 10, 2015
The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanismsHwan-Jin Hwang, Hye Soo Chung, Tae Woo Jung, et al.
Endocrine|March 28, 2013
Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitusHye Jin Yoo, Soon Young Hwang, Ho Cheol Hong, et al.
Pageof 4